TET2 and acute myeloid leukemia: The phenotype observed in AML mice was not observed in littermates that have wild-type FLT3 but still harbored loss of both TET2 and p53 (Supplementary Figure 4), supporting our hypothesis that FLT3-ITD would lead to increased abundance of cDCs in vivo.